Skip to content

Clinical trials

Terminated Phase 3 Renal Insufficiency, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Status: Terminated Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20074
20081
20092
20104
20113
20133
20142
20171
20183
20193
20201
20214
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Tanabe Pharma Corporation4
AstraZeneca2
Biogen2
Cara Therapeutics, Inc.2
AMAG Pharmaceuticals, Inc.1
AbbVie1
Abbott1
Alexion Pharmaceuticals, Inc.1
Artegraft, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic37
Hyperphosphatemia5
Anemia4
Hyperparathyroidism, Secondary4
Hyperkalemia3
Kidney Failure, Chronic3
Acidosis2
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Hyperparathyroidism2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.